Notice NOT-OH-20-004 from the NIH Guide for Grants and Contracts

Notice NOT-OD-20-053 from the NIH Guide for Grants and Contracts

One year of experience with specialized instrumentation and techniques (microscopy, bioinformatics, statistics, etc.). This is a 9-Month, Faculty 5 position. $51,373 - $61,647 a year
From Laramie County Community College - Sat, 21 Dec 2019 00:37:43 GMT - View all Cheyenne, WY jobs

£34,546-£41,801: Wellcome Sanger Institute: Senior Research Assistant #{%22news%22:{}}">Genome Wellcome Campus. We hold an Athena SWAN Bronze Award and will consider all individuals without Hinxton, Cambridgeshire, England

Negotiable: SRG: Biotech based in the Cambridge area is an innovative company working in diagnostic development is looking for an experienced data analysis scientist. Cambridge, England

Notice NOT-RM-20-003 from the NIH Guide for Grants and Contracts

Notice NOT-OD-20-022 from the NIH Guide for Grants and Contracts

Notice NOT-EB-19-022 from the NIH Guide for Grants and Contracts

Competitive: Astex Pharmaceuticals: Astex Pharmaceuticals is a world leader in innovative drug discovery and development. The company Cambridge, Cambridgeshire

Competitive: Astex Pharmaceuticals: Astex Pharmaceuticals is a world leader in innovative drug discovery and development. The company Cambridge, Cambridgeshire

Competitive: Astex Pharmaceuticals: Astex Pharmaceuticals is a world leader in innovative drug discovery and development. The company Cambridge, Cambridgeshire

Competitive Salary: EMBL: Software Developer Location: EMB Cambridge, Cambridgeshire, England

Funding Opportunity RFA-CA-20-026 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI U2C Resource-Related Multi-Component Projects and Centers. The applicants should propose to expand upon original research question(s) from specific projects or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this FOA are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities. As a component of the NCI IMAT program, this FOA aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery.

Funding Opportunity RFA-CA-20-022 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI U01 research projects. The applicants should propose to expand upon the original research question(s) or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this FOA are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities. As a component of the NCI IMAT program, this FOA aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery.

Funding Opportunity RFA-CA-20-021 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI R01 research projects. The applicants should propose to expand upon the original research question(s) or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this FOA are meant to incentivize independent validation and accelerate the adoption of these emerging technologies by appropriate research communities. As a component of the NCI IMAT program, this FOA aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery.

Funding Opportunity RFA-CA-20-025 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI P50 specialized centers. The applicants should propose to expand upon original research question(s) from specific projects or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this FOA are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities. As a component of the NCI IMAT program, this FOA aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery.

Funding Opportunity RFA-CA-20-024 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI P01 program projects. The applicants should propose to expand upon original research question(s) from specific projects or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this FOA are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities. As a component of the NCI IMAT program, this FOA aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery.

Funding Opportunity RFA-CA-20-023 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI U54 Resource-Related Research Projects. The applicants should propose to expand upon original research question(s) from specific projects or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this FOA are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities. As a component of the NCI IMAT program, this FOA aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery.

Funding Opportunity RFA-RM-20-008 from the NIH Guide for Grants and Contracts. This Limited Competition Funding Opportunity Announcement (FOA) invites an application from the currently funded NIH Common Fund-supported Four-Dimensional Nucleome (4DN) Data Coordination and Integration Center (DCIC) to support Phase 2 of the 4DN program. The 4DN DCIC will have two major areas of responsibility: (1) Data Standards, Storage, Analysis, and Dissemination; and, (2) Consortium Interactions and Outreach. The 4DN DCIC will collect, store, curate, and disseminate all 4DN-generated data, metadata, analysis and visualization tools, computational models, and navigable reference maps. The DCIC will also lead the development of data and metadata standards, implementation of processing pipelines and analysis and visualization tools, and facilitate the broader use of 4DN data by experts and non-experts through outreach activities.

Funding Opportunity RFA-RM-20-007 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites an application from the currently funded NIH Common Fund-supported 4D Nucleome Network (4DN) Organizational Hub (4DN-OH) to support Phase 2 efforts of this program. The overall programmatic goal of the OH is to provide administrative infrastructure for the 4DN Network and facilitate and coordinate all common activities of the 4DN Network.